On 18 May at the 2025 American Thoracic Society (ATS) International Conference, a poster presentation by Sivagurunathan Sutharsan and colleagues from University Medicine Essen, Ruhrlandklinik ...

Vertex Pharmaceuticals missed Wall Street estimates for quarterly results on Monday due to lower-than-expected sales of its cystic fibrosis (CF) drug Trikafta, sending shares down 2.5% after the bell.

Patients in the Alyftrek groups of both trials also experienced more improved sweat chloride concentrations vs. patients in the Trikafta groups at the 24-week mark (least squares mean treatment ...

Findings showed Trikafta significantly improved ppFEV 1 at week 24 compared with placebo (treatment difference, 9.2 [95% CI, 7.2-11.3]; P <.0001).

New report finds that Trikafta patients’ admissions to hospital fell by an average of 65 per cent over one year – but at a list price of over $300,000, the drug is not yet considered cost ...

From a young age, Emily Naismith watched her peers die from cystic fibrosis. The drug Trikafta gave her a future but she says forming a new identity has been complex.

Mononucleosis results from Epstein-Barr virus infection. People with the condition may develop a range of symptoms, including a skin rash. Learn more.

People with cystic fibrosis-related diabetes who are using Trikafta are more at risk of putting on weight compared to those not taking the medication, new evidence has found. Otherwise known as ...

Trikafta, he told me, made a clear difference for this baby girl. Cystic fibrosis is caused by an imbalance of salt and water in the body, and this affects developing organs even before birth.

Trikafta’s sticker price is more than $300,000 a year. Insurance typically covers most of that cost—minus what can be significant co-pays and deductibles—and Vertex offers co-pay assistance.

UPDATE: Vertex beats own record in cystic fibrosis as next-gen treatment goes up against Trikafta By Gabrielle Masson Feb 5, 2024 7:50pm Vertex Pharmaceuticals cystic fibrosis Trikafta FDA ...